VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AUNAAuna S.A.
$5.15$381M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAUNABalance Sheet

Auna S.A. (AUNA) Balance Sheet

9Y historyFree accessUpdated daily

The company maintains a debt-to-equity ratio of 1.99 as of 2026Q1, highlighting a persistent reliance on external financing that constrains financial flexibility.

AUNA Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17
Total Current Assets2B1.84B1.7B1.55B1.2B671.27M836.18M441.95M446.78M156.01M
Cash & Short-Term Investments428.92M365.65M335.97M334.26M208.69M138.77M343.45M36.08M110.87M32.5M
Cash Only408.59M335.41M235.75M241.13M208.69M138.77M343.45M36.08M110.87M32.5M
Short-Term Investments20.33M30.23M100.23M93.13M000000
Accounts Receivable1.12B1.06B961.89M860.92M574.17M352.66M370.64M285.6M238.12M69.98M
Days Sales Outstanding86.2187.8580.0581.0785.4866.9193.775.4100.9235.34
Inventory159.21M164.78M143.76M130.52M87.58M61.15M52.57M37.06M31.83M17.91M
Days Inventory Outstanding19.8822.119.7219.5220.3418.0520.9816.0223.3415.49
Other Current Assets291.5M258.49M262.25M223.45M324.66M118.68M69.52M83.21M65.96M35.63M
Total Non-Current Assets5.69B5.45B5.38B6.14B5.4B2.15B1.81B1.45B1.29B541.23M
Property, Plant & Equipment2.47B2.4B2.41B2.71B2.46B1.35B1.2B956.71M794.64M451.2M
Fixed Asset Turnover1.86x1.83x1.82x1.43x0.99x1.42x1.20x1.45x1.08x1.60x
Goodwill02.7B1.75B2.07B1.81B184.96M197.71M188.07M193.39M20.59M
Intangible Assets00902.6M1.06B953.03M325.03M293.18M243.53M238.19M27.39M
Long-Term Investments182.1M91.4M25.69M20.87M13.1M14.29M12.1M9.91M9.21M2.44M
Other Non-Current Assets100.35M26.91M89.57M110.44M39.88M163.41M29.63M51.14M57.95M39.63M
Total Assets7.69B7.3B7.08B7.69B6.59B2.82B2.65B1.89B1.74B697.25M
Asset Turnover0.61x0.60x0.62x0.50x0.37x0.68x0.54x0.73x0.49x1.04x
Asset Growth %9.3%3.06%-7.92%16.62%133.52%6.51%40.17%8.68%149.58%-
Total Current Liabilities1.84B1.67B1.95B1.69B2.85B698.49M566.75M589.92M475.57M254.16M
Accounts Payable1.1B1.05B931.26M749.35M512.59M454.1M351.25M230.31M224.77M83.38M
Days Payables Outstanding130.49141.26127.75112.07119.02134.01140.2199.54164.8172.08
Short-Term Debt400M345.59M654.23M385.3M2.04B29.73M18.44M182.16M109.84M71.16M
Deferred Revenue (Current)21.94M97.99K040.12M12.01M326K446K000
Other Current Liabilities38.21M267.95M176.61M205.28M127.47M156.06M131.4M91.19M91.17M62.7M
Current Ratio1.09x1.11x0.88x0.92x0.42x0.96x1.48x0.75x0.94x0.61x
Quick Ratio1.00x1.01x0.80x0.84x0.39x0.87x1.38x0.69x0.87x0.54x
Cash Conversion Cycle-24.4-31.31-27.98-11.48-13.21-49.05-25.53-8.12-40.56-21.26
Total Non-Current Liabilities3.93B3.86B3.51B4.22B2.19B1.58B1.43B722.56M731.26M189.66M
Long-Term Debt3.29B3.22B2.97B3.38B1.31B1.32B1.19B486.99M544.87M108.74M
Capital Lease Obligations384.48M94.23M115.43M126.18M134.84M123.7M127.52M151.28M87.9M64.56M
Deferred Tax Liabilities887.25M291.06M0495.83M470.16M53.57M51.15M000
Other Non-Current Liabilities257.46M263.01M431.54M225.04M277.25M78.9M62.59M84.29M98.49M16.36M
Total Liabilities5.77B5.53B5.46B5.91B5.04B2.28B2B1.31B1.21B443.82M
Total Debt3.82B3.66B3.77B3.92B3.51B1.49B1.35B848.23M747.54M244.71M
Net Debt3.41B3.32B3.53B3.68B3.3B1.35B1.01B812.15M636.67M212.22M
Debt / Equity1.99x2.07x2.32x2.21x2.25x2.73x2.08x1.47x1.40x0.97x
Debt / EBITDA4.42x4.28x3.90x5.02x9.21x7.27x7.40x3.79x6.09x2.75x
Net Debt / EBITDA3.95x3.89x3.66x4.71x8.66x6.59x5.52x3.63x5.18x2.38x
Interest Coverage1.38x1.46x1.38x0.77x0.77x0.97x0.68x3.08x3.53x2.53x
Total Equity1.92B1.77B1.62B1.78B1.56B545.91M652.07M578.82M533.34M253.43M
Equity Growth %42.24%8.83%-8.65%14.02%185.41%-16.28%12.66%8.53%110.45%-
Book Value per Share26.3758.6923.9940.4534.5911.3914.4413.4614.296.82
Total Shareholders' Equity1.74B1.6B1.48B1.47B1.06B495.82M600.93M562.28M517.61M252.07M
Common Stock17.39M17.39M17.39M8.82M236.55M236.55M236.55M236.55M236.55M204.36M
Retained Earnings-186.07M414.5M-273.53M-366.9M-90.98M-45.49M-12.62M17.24M-38.17M-58.47M
Treasury Stock0000000000
Accumulated OCI696.45M-40.88M524.78M1.82B533.37M-81.28M-9.04M-77.56M-66.81M-69.94M
Minority Interest179.81M165.58M145.72M311.28M493.08M50.09M51.14M16.54M15.73M1.36M

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

High leverage and integration

Elevated Leverage Constrains Financial Flexibility

According to the latest quarterly filings, Auna maintains a debt-to-equity ratio of 1.99 as of 2026Q1, reflecting a persistent reliance on external financing to support its regional expansion strategy, which warrants close monitoring given the company's historical struggle to maintain consistent profitability across its cross-border clinical operations.

The company's debt load of $3.8B relative to $1.7B in equity suggests a capital structure that is heavily skewed toward debt, likely to fund the aggressive acquisition of clinical assets. This high leverage profile leaves little room for operational error, particularly if interest rate environments or currency fluctuations impact the cost of servicing these obligations.

Goodwill Concentration Signals Integration Risk

Based on reported financial statements, Auna's balance sheet is heavily weighted toward intangible assets, with goodwill reaching $2.8B in 2026Q1, representing a significant portion of the $7.7B total asset base and highlighting the company's reliance on successful post-acquisition synergy realization to justify its current valuation.

The substantial goodwill balance indicates that a large portion of the company's asset base is derived from acquisition premiums rather than tangible clinical infrastructure. Investors should be wary of potential impairment risks if the anticipated synergies from the Mexican and Colombian expansions fail to materialize as expected.

Tight Liquidity Buffers Amidst Expansion

As reported in recent balance sheet data, Auna's current ratio stands at 1.09 in 2026Q1, a marginal improvement from previous periods but still indicative of a narrow liquidity buffer that may struggle to absorb unexpected shocks in working capital requirements or sudden spikes in medical loss ratios.

While the current ratio has stabilized above parity, the company's cash position of $408.6M remains relatively thin compared to its total liabilities. This suggests that the firm is operating with limited short-term flexibility, making it highly dependent on consistent cash flow generation from its prepaid plan segment to meet immediate obligations.

Retained Earnings Volatility Reflects Instability

Financial statements reveal that Auna's retained earnings remain in negative territory at -$186.1M as of 2026Q1, a trend that underscores the company's ongoing difficulty in generating sustained bottom-line growth despite its significant regional footprint and aggressive expansion into high-acuity healthcare markets across Latin America.

The persistent negative retained earnings suggest that the company has yet to reach a stage of mature, self-sustaining profitability. This capital structure profile implies that equity holders are effectively subsidizing the company's growth phase, which may lead to future dilution if the firm requires additional capital to stabilize its balance sheet.

AUNA — Frequently Asked Questions

Quick answers to the most common questions about buying AUNA stock.

What are the total assets of Auna S.A. (AUNA)?

As of 2025, Auna S.A. (AUNA) had total assets of $7.30B including $1.84B in current assets.

How much debt does Auna S.A. (AUNA) have?

Auna S.A. (AUNA) carries total debt of $3.66B, offset by $365.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Auna S.A.?

Auna S.A. (AUNA) has total shareholders' equity (book value) of $1.60B ($58.69 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Auna S.A.'s current ratio and liquidity?

Auna S.A. (AUNA) reported a current ratio of 1.11x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.